Leopold, W R <br/><br/>
Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia.  [electronic resource] 

 -  NCI monographs : a publication of the National Cancer Institute  1987 
 - 99-104 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0893-2751 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Synergism<br/>Fluorouracil--administration & dosage<br/>Leukemia P388--drug therapy<br/>Leukemia, Experimental--drug therapy<br/>Mice<br/>Quinazolines--administration & dosage<br/>Thioguanine--administration & dosage<br/>Trimetrexate<br/>Vincristine--administration & dosage